Qin Wu

1.8k total citations · 1 hit paper
29 papers, 752 citations indexed

About

Qin Wu is a scholar working on Molecular Biology, Biomedical Engineering and Cancer Research. According to data from OpenAlex, Qin Wu has authored 29 papers receiving a total of 752 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 6 papers in Biomedical Engineering and 5 papers in Cancer Research. Recurrent topics in Qin Wu's work include Epigenetics and DNA Methylation (5 papers), Cancer-related gene regulation (4 papers) and Enzyme Catalysis and Immobilization (3 papers). Qin Wu is often cited by papers focused on Epigenetics and DNA Methylation (5 papers), Cancer-related gene regulation (4 papers) and Enzyme Catalysis and Immobilization (3 papers). Qin Wu collaborates with scholars based in China, United States and Canada. Qin Wu's co-authors include C.H. Arrowsmith, Matthieu Schapira, Dalia Baršytė-Lovejoy, Hongxia Liu, Yuhua Wang, Yuyang Jiang, Yu Chen, Chunyan Tan, Yuyang Jiang and Dan Gao and has published in prestigious journals such as Advanced Materials, Nature Communications and ACS Nano.

In The Last Decade

Qin Wu

25 papers receiving 744 citations

Hit Papers

Protein arginine methylation: from enigmatic functions to... 2021 2026 2022 2024 2021 50 100 150 200 250

Peers

Qin Wu
Ana S. Leal United States
Jing Su China
Soumyasri Das Gupta United States
Ana S. Leal United States
Qin Wu
Citations per year, relative to Qin Wu Qin Wu (= 1×) peers Ana S. Leal

Countries citing papers authored by Qin Wu

Since Specialization
Citations

This map shows the geographic impact of Qin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qin Wu more than expected).

Fields of papers citing papers by Qin Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qin Wu. The network helps show where Qin Wu may publish in the future.

Co-authorship network of co-authors of Qin Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Qin Wu. A scholar is included among the top collaborators of Qin Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qin Wu. Qin Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Jun, Yao Shen, Yi Wang, et al.. (2025). Metal‐polyphenol Multistage Competitive Coordination System for Colorimetric Monitoring Meat Freshness. Advanced Materials. 37(21). e2503246–e2503246. 10 indexed citations
2.
Du, Zhen, Xiaoqiu Wu, Qin Wu, et al.. (2025). Molecular bioengineering of functional nucleic acids. Nature Reviews Bioengineering. 4(2). 153–170.
3.
Liu, Li‐Ping, Fan Qiu, Dawei Wu, et al.. (2025). Crocetin, a versatile carotenoid: Novel insights into pharmacological effects, molecular mechanisms, and therapeutic potential. International Immunopharmacology. 162. 115125–115125.
5.
Yang, Rui, Yingfei Xue, Yu Zhang, et al.. (2025). Increasing RB1 Expression by Targeting EZH2 in Triple‐Negative Breast Cancer. Journal of Cellular and Molecular Medicine. 29(5). e70384–e70384. 1 indexed citations
6.
Wei, Juan, Xueyuan Zhou, Yong Wei, et al.. (2025). Protocol to identify small-molecule inhibitors against cancer drug resistance. STAR Protocols. 6(1). 103605–103605.
7.
Duan, Qiao, Hao‐Ran Jia, Kejing Zhang, et al.. (2024). Multivalent Aptamer‐Based Lysosome‐Targeting Chimeras (LYTACs) Platform for Mono‐ or Dual‐Targeted Proteins Degradation on Cell Surface. Advanced Science. 11(17). e2308924–e2308924. 30 indexed citations
8.
Zhang, Ying, Yanyuan Wu, Ting Fu, et al.. (2024). The Emerging Era of Molecular Medicine. ACS Nano. 18(45). 30911–30918. 3 indexed citations
9.
Liu, Xueying, et al.. (2023). Targeting TAF1 with BAY-299 induces antitumor immunity in triple-negative breast cancer. Biochemical and Biophysical Research Communications. 665. 55–63. 7 indexed citations
11.
Liu, Yan, Xin Chen, Jiayi Yang, et al.. (2023). RNA-seq analysis reveals an immunomodulatory peptide from highland barley activating RAW264.7 macrophages via TNF/NF-κB signaling pathway. Functional & Integrative Genomics. 23(3). 253–253. 10 indexed citations
12.
Wu, Qin, David Heidenreich, Stanley Zhou, et al.. (2019). A chemical toolbox for the study of bromodomains and epigenetic signaling. Nature Communications. 10(1). 1915–1915. 82 indexed citations
14.
Ge, Yuqiu, Qin Wu, Gaoxiang Ma, et al.. (2017). Hypermethylation of EIF4E promoter is associated with early onset of gastric cancer. Carcinogenesis. 39(1). 66–71. 15 indexed citations
16.
Shao, Xiaojian, Dan Gao, Yini Wang, et al.. (2016). Application of metabolomics to investigate the antitumor mechanism of flavopiridol in MCF-7 breast cancer cells. Journal of Chromatography B. 1025. 40–47. 25 indexed citations
17.
Yin, Xin, Jianfang Li, Chunjuan Wang, et al.. (2015). Improvement in the thermostability of a type A feruloyl esterase, AuFaeA, from Aspergillus usamii by iterative saturation mutagenesis. Applied Microbiology and Biotechnology. 99(23). 10047–10056. 22 indexed citations
19.
Li, Lulu, Yu Chen, Qinsheng Sun, et al.. (2013). Novel synthetic acridine derivatives as potent DNA-binding and apoptosis-inducing antitumor agents. Bioorganic & Medicinal Chemistry. 21(14). 4170–4177. 70 indexed citations
20.
Gao, Dan, Qin Wu, Feng Liu, et al.. (2013). Exploration of N-(2-aminoethyl)piperidine-4-carboxamide as a potential scaffold for development of VEGFR-2, ERK-2 and Abl-1 multikinase inhibitor. Bioorganic & Medicinal Chemistry. 21(18). 5694–5706. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026